Easy-to-read informed consent forms for hematopoietic cell transplantation clinical trials
- PMID: 21806948
- PMCID: PMC3242929
- DOI: 10.1016/j.bbmt.2011.07.022
Easy-to-read informed consent forms for hematopoietic cell transplantation clinical trials
Abstract
Informed consent is essential to ethical research and is requisite to participation in clinical research. Yet most hematopoietic cell transplantation (HCT) informed consent forms (ICFs) are written at reading levels that are above the ability of the average person in the United States (U.S.). The recent development of ICF templates by the National Cancer Institute, National Institutes of Health, and the National Heart Blood and Lung Institute have not resulted in increased patient comprehension of information. Barriers to creating Easy-to-Read ICFs that meet U.S. federal requirements and pass institutional review board (IRB) review are the result of multiple interconnected factors. The Blood and Marrow Transplant Clinical Trials Network (BMT CTN) formed an ad hoc review team to address concerns regarding the overall readability and length of ICFs used for BMT CTN trials. This paper summarizes recommendations of the review team for the development and formatting of Easy-to-Read ICFs for HCT multicenter clinical trials, the most novel of which is the use of a 2-column format. These recommendations intend to guide the ICF writing process, simplify local IRB review of the ICF, enhance patient comprehension, and improve patient satisfaction. The BMT CTN plans to evaluate the impact of the Easy-to-Read format compared with the traditional format on the informed consent process.
Copyright © 2012 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.
Figures
References
-
- Comprehensive Working Group on Informed Consent in Cancer Clinical Trials for the National Cancer Institute: Recommendations for the Development of Informed Consent Documents for Cancer Clinical Trials. [Accessed 3/19/2010];NCI, NIH Publication No. 98–4355. 1998 Available at: http://www.cancer.gov/clinicaltrials/understanding/simplification-of-inf....
-
- US Department of Health and Human Services Office for Human Research Protections. OHRP Informed Consent Frequently Asked Questions. 2008 November; Retrieved July 1, 2010, from http://www.hhs.gov/ohrp/informconsfaq.html.
-
-
45 CFR 46. 116: Protection of Human Subjects; Revised 6/18/1991.
-
-
- Tait A, Voepel-Lewis T, Malviya S, Philipson S. Improving the readability and processability of a pediatric informed consent document: Effect on parents’ understanding. Arch Pediatr Adolesc Med. 2005;159:347–352. - PubMed
-
- Cox K. Informed consent and decision-making: patients’ experiences of the process of recruitment to phases I and II anti-cancer drug trials. Patient Educ Couns. 2002;46(1):31–38. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
